Madrigal Pharmaceuticals, Inc. MDGL Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s common stock par value per share.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s common stock par value per share?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported common stock par value per share of $0.00 in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s common stock par value per share changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s common stock par value per share?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.